Revvity
RVTY
381 hedge funds and large institutions have $8.15B invested in Revvity in 2018 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 115 increasing their positions, 138 reducing their positions, and 66 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
37% more call options, than puts
Call options by funds: $3.49M | Put options by funds: $2.54M
0.1% more ownership
Funds ownership: 96.04% → 96.14% (+0.1%)
4% less funds holding
Funds holding: 398 → 381 (-17)
17% less repeat investments, than reductions
Existing positions increased: 115 | Existing positions reduced: 138
18% less first-time investments, than exits
New positions opened: 54 | Existing positions closed: 66
21% less capital invested
Capital invested by funds: $10.3B → $8.15B (-$2.19B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Select Equity Group
New York
|
+$92.4M |
| 2 |
BlackRock
New York
|
+$40.8M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$33.4M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$29.9M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$27.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$67.5M |
| 2 |
Millennium Management
New York
|
-$23.6M |
| 3 |
SOMRS
State of Michigan Retirement System
Lansing,
Michigan
|
-$17.3M |
| 4 |
Impax Asset Management Group
London,
United Kingdom
|
-$15.8M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$15.2M |
RVTY Hedge Fund Activity: Q4 2018 in Review
381 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Revvity (RVTY) for Q4 2018, worth a combined $8.15B — down 21% from $10.3B a quarter earlier.
Sellers outnumbered buyers: 66 funds closed out of RVTY and 54 opened new positions — a net loss of 12 holders — while 138 trimmed existing stakes and 115 added.
The largest buyer was Select Equity Group, adding an estimated $92.4M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $67.5M sold.
- 381 institutional investors held Revvity (RVTY) as of Q4 2018, down from 398 in Q3 2018.
- Funds reported $8.15B of Revvity stock for Q4 2018, down 21% quarter-over-quarter.
- 54 funds opened new Revvity positions in Q4 2018 and 66 closed out, a net change of -12 holders.
- The largest Revvity buyer in Q4 2018 was Select Equity Group, an estimated $92.4M added.
- The largest Revvity seller in Q4 2018 was PFM Health Sciences, an estimated $67.5M sold.
Based on aggregated 13F filings for Q4 2018.